Ulrich Massing
Papers
2
Total Citations
24
H-Index
2
About
Ulrich Massing is a leading figure in pharmaceutical research, specializing in drug delivery, lipofection, and high-throughput permeability screening. His work centers on developing innovative in vitro tools to predict drug absorption and optimize therapeutic formulations. Massing’s most notable contribution is the advancement of the Phospholipid Vesicle-Based Drug Permeability Assay, a groundbreaking method that accurately models passive drug absorption in humans. His 2008 study on automating this assay for high-throughput screening represents a critical step in streamlining drug discovery, cited 14 times for its practical impact on oral absorption prediction. Earlier, Massing pioneered a high-throughput screening method for identifying new lipofection reagents (2001, 10 citations), addressing a key bottleneck in gene therapy and non-viral vector design. His work bridges fundamental biophysics and applied pharmacology, offering researchers robust, scalable tools to evaluate drug candidates. Massing’s contributions have been instrumental in reducing reliance on animal models and accelerating early-stage drug development, making him a respected authority in permeability assay technology and lipid-based delivery systems.
Research Focus
Key Achievements
Top Papers
- 1
- 2